Understanding Myeloperoxidase (MPO): A Comprehensive Clinical Guide

Myeloperoxidase (MPO) is a critical enzyme stored in the azurophilic granules of neutrophils and, to a lesser extent, in monocytes. It plays a pivotal role in the innate immune system, acting as a potent antimicrobial agent. In clinical diagnostics, MPO levels are measured to assess inflammatory states, cardiovascular risk, and the presence of specific autoimmune conditions.

As an orthopedic and clinical specialist, understanding the role of MPO is essential for managing systemic inflammatory responses that can complicate musculoskeletal recovery and chronic pain syndromes.

Technical Specifications and Biochemical Mechanism

At the molecular level, MPO is a heme-containing peroxidase enzyme. Its primary function is to catalyze the production of hypochlorous acid (HOCl) from hydrogen peroxide ($H_2O_2$) and chloride ions ($Cl^-$).

The Mechanism of Action

1. Activation: When neutrophils are activated by pathogens or inflammatory signals, they undergo a "respiratory burst."
2. Enzymatic Reaction: MPO utilizes the hydrogen peroxide produced during this burst to oxidize chloride ions.
3. Antimicrobial Effect: The resulting hypochlorous acid is a highly reactive oxidant that kills bacteria, fungi, and viruses by damaging their cellular components.

While essential for immune defense, excessive MPO activity or localized release can lead to collateral tissue damage, promoting oxidative stress and chronic inflammation in surrounding tissues, including cartilage and synovial linings.

Clinical Indications and Diagnostic Utility

The MPO test is not a routine screening tool but is indicated in specific clinical scenarios where inflammatory burden or vascular integrity is in question.

Primary Clinical Indications

• Cardiovascular Risk Assessment: Elevated MPO levels are associated with the destabilization of atherosclerotic plaques.
• Vasculitis Diagnosis: MPO is a major target for Anti-Neutrophil Cytoplasmic Antibodies (ANCA), specifically in microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA).
• Chronic Inflammatory Monitoring: Used to gauge the activity level of systemic inflammatory diseases.
• Orthopedic Considerations: Monitoring systemic inflammation in patients with severe rheumatoid arthritis or post-surgical systemic inflammatory response syndrome (SIRS).

Summary of Clinical Utility

Specimen Collection and Laboratory Procedures

Accurate MPO measurement requires strict adherence to pre-analytical protocols to ensure the stability of the enzyme and the integrity of the sample.

Collection Guidelines

• Sample Type: Serum or plasma (usually EDTA or Heparin).
• Storage: Samples should be processed promptly. If processing is delayed, samples must be refrigerated at 2-8°C. For long-term storage, aliquots should be frozen at -70°C.
• Hemolysis Warning: Hemolyzed samples can interfere with spectrophotometric assays for MPO activity. Always reject grossly hemolyzed samples.

Interfering Factors

• Medications: Certain anti-inflammatory drugs may suppress neutrophil activation, potentially lowering MPO levels.
• Lipemia: High triglyceride levels can interfere with optical density readings in automated assays.
• Bilirubin: Elevated bilirubin may cause false-negative results in certain colorimetric enzymatic assays.

Interpreting MPO Results: Reference Ranges

Reference ranges can vary significantly between laboratories depending on the methodology used (e.g., ELISA, activity assays, or chemiluminescence).

General Reference Ranges (Indicative Only)

• Healthy Adults: Typically < 100 ng/mL (Varies by assay manufacturer).
• Elevated Levels: Often noted in acute coronary syndromes or active vasculitis flare-ups.

Note: Always refer to the specific laboratory report's reference intervals, as standardization of MPO assays remains a clinical challenge.

Causes of Abnormal MPO Levels

Elevated MPO Levels

• Acute Coronary Syndrome (ACS): High levels indicate plaque instability and high risk of myocardial infarction.
• Active Vasculitis: High titers of MPO-ANCA are diagnostic for specific forms of systemic vasculitis.
• Severe Infections: Massive neutrophil recruitment leads to systemic MPO elevation.
• Chronic Obstructive Pulmonary Disease (COPD): Chronic inflammation in the lungs often correlates with elevated circulating MPO.

Decreased MPO Levels

• MPO Deficiency: A genetic condition (often asymptomatic) where neutrophils lack MPO. While usually benign, it may increase susceptibility to severe Candida infections in diabetic patients.
• Neutropenia: A low neutrophil count will inherently lead to lower circulating MPO.

Risks, Side Effects, and Contraindications

Testing for MPO is a blood-based diagnostic procedure and carries minimal risk.

• Risks: Standard venipuncture risks include bruising, localized hematoma, or lightheadedness.
• Contraindications: There are no absolute contraindications to the blood test itself. However, clinicians should interpret results in the context of the patient's entire clinical picture, as MPO is a non-specific marker of inflammation.
• Clinical Caution: An MPO-ANCA positive result does not automatically equate to organ-threatening disease; it must be correlated with biopsy, clinical symptoms (e.g., hematuria, pulmonary infiltrates), and other inflammatory markers like CRP and ESR.

Frequently Asked Questions (FAQ)

1. What exactly does the MPO test measure?

The MPO test measures either the concentration of the myeloperoxidase protein in the blood or the functional activity of the enzyme, depending on the specific laboratory method used.

2. Is MPO testing used to diagnose heart attacks?

It is used as a risk stratification tool rather than a diagnostic tool for an active heart attack. It helps identify patients who are at higher risk for future cardiac events.

3. What is the link between MPO and Orthopedics?

Systemic inflammation, often reflected by elevated MPO, can exacerbate joint degradation and slow tissue healing in patients with chronic autoimmune conditions like rheumatoid arthritis.

4. Can MPO levels be lowered through diet?

While there is no specific "MPO-lowering diet," anti-inflammatory diets (rich in omega-3s and antioxidants) may help reduce overall systemic inflammation and neutrophil activation.

5. What are MPO-ANCA antibodies?

These are autoantibodies that target the MPO enzyme. They are highly specific markers for microscopic polyangiitis and other small-vessel vasculitides.

6. Is MPO deficiency dangerous?

In most people, MPO deficiency is asymptomatic. However, it can make it harder for the body to fight off specific fungal infections, particularly in patients with diabetes.

7. Does exercise affect MPO levels?

Strenuous, unaccustomed exercise can lead to a transient increase in MPO levels due to the body's acute inflammatory response to muscle micro-trauma.

8. How often should MPO be monitored in vasculitis patients?

Monitoring frequency is determined by the rheumatologist, typically during the induction phase of treatment or when a flare-up is suspected.

9. Can medications cause false results?

Yes, medications that stabilize neutrophils or suppress the immune system can potentially lower MPO levels, potentially masking an underlying inflammatory state.

10. Does high MPO always mean I have a disease?

No. MPO is a sensitive marker of neutrophil activation. It can be elevated due to a common cold, minor infection, or even stress, so it should never be interpreted in isolation.

Conclusion

Myeloperoxidase (MPO) serves as a potent window into the body’s innate immune activity and cardiovascular health. For the medical professional, it is a tool of precision—a way to quantify the intensity of the neutrophil-driven inflammatory response. Whether you are managing a patient with suspected vasculitis or assessing the inflammatory burden in a chronic orthopedic case, MPO provides critical data that, when combined with clinical acumen, leads to better diagnostic accuracy and improved patient outcomes.

Always ensure that MPO testing is ordered with a clear clinical intent and interpreted alongside standard inflammatory markers to provide a holistic view of the patient’s health status.